Image

The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme

The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme

Non Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

Displaced people, like refugees or asylum seekers, have high rate of potentially traumatic events. PTSD is one of the most common psychiatric trouble in this population. It requires specialized support and psychosocial program. Narrative Exposure Therapy (NET), a german psychotherapy, was developed in the 2000 to specifically treat psycho-trauma in this population. It is brief, effective on complex trauma and can be delivered by trained non-caregivers. All published randomized studies have conclued that NET is effetive, but there are still insifficient numbers to make recomendations. To our knowledge, NET has never been tested in France. In Marseille, SINDIANE is a community support and program for refugees and asylum seekers. Many workshops led by peer workers are offered to increase empowerment of beneficiaries and hel them to recover. The development of a NET workshop would make it possible to combine community support and specific and validated psychotherapy. Through this study, the investigators hypothesize that tratment of PTSD with NET in the community-based SINDIANE program decrease symptoms of PTSD.

Description

Methods and design Forty-six participants with a diagnosis of PTSD disorder within the SINDIANE program will be recruited. A prospective single-blind randomized clinical trial will be conducted comparing two groups, one participant in the classic SINDIANE program and one being treated in addition by NET workshp. The evaluations will be done at the baseline, after the intervention and at three and six months follow-up. IN addition, the qualitative and participatory research method called photovoice will be used to better understand the experiences of participants who recieve NETtroughout their recovery.

The primary objective is the assessment of the symptom intensity score (PCL-5) of posttraumatic stress disorder (PTSD).

Secondary objectives are represented by:

  • The assessment of the stability over time of the PTSD symptom intensity score at three months and six months (PCL-5).
  • Assessment of the intensity of global psychiatric comorbidities (RHS-15)
  • Evaluation of life indicators: ability to act, quality of life (GSE self-efficacy questionnaire).

Eligibility

Inclusion Criteria:

  • Woman over 18
  • Refugee or asylum seeker (habing applied to OFFPRA or with a residence permit)
  • Belonging to the SINDIANE community project
  • Having been exposed to at least one traumatic event (according to the DSM 5 definition validated by a doctor)
  • Having a PCL5 score greater than 23
  • Agreeing to participate in the study with an informed consent signed by the subject after explanations given by the investigating psychiatrist
  • Patient affiliated to a social security health care
  • Patient able to read and write arabic or french

Exclusion Criteria:

  • Be under the age of 18
  • Be included in another intervention research
  • Presence of severe mental retardation or dementia according to DSM5
  • Persons benefiting from special protection : under article L3212-1 and L3213-1 of the Public Health Code
  • Persons referred to in articles L1121-5 to L1121-8 of the CSP
  • Existence of a high suicide risk assessed by the R.U.D.
  • Patient subject to a compulsory care measure (Law n°2011-803 of july 5, 2011 relating to the rights and protection of persons subject to psychiatric care and the terms of care)
  • Patient refusing to sign the consent or unable to receive the information necessary to give informed consent

Study details
    Post-traumatic Stress Disorder (PTSD)

NCT05407337

Assistance Publique Hopitaux De Marseille

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.